C4 Therapeutics Inc. (CCCC)
NASDAQ: CCCC
· Real-Time Price · USD
2.46
0.11 (4.68%)
At close: Aug 15, 2025, 3:59 PM
2.46
0.20%
After-hours: Aug 15, 2025, 06:51 PM EDT
C4 Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
PE Ratio | -0.98 | -1.08 | -1.84 | -4.02 | -4.71 | -4.89 | -2.08 | -0.85 | -0.94 | -1.13 | -2 | -3.41 | -3.35 | -9.26 | -24.93 | -21.94 | -18.37 |
PEG Ratio | n/a | 0.04 | -0.05 | -0.12 | 0.13 | 0.12 | -0.09 | 0.03 | -0.16 | 0.17 | -0.13 | -0.24 | 0.22 | -0.09 | 0.67 | n/a | -4.5 |
PS Ratio | n/a | 15.66 | 49.10 | 25.83 | 27.80 | 182.40 | 88.74 | 8.27 | 50.65 | 40.96 | 101.23 | 63.52 | 26.61 | 154.19 | 77.77 | 254.89 | 169.66 |
PB Ratio | 0.58 | 0.58 | 1.18 | 1.64 | 1.35 | 2.15 | 1.18 | 0.42 | 0.58 | 0.59 | 1.00 | 1.35 | 1.07 | 3.24 | 4.01 | 5.43 | 3.99 |
P/FCF Ratio | -8.29 | -3.4 | -14.18 | -16.45 | -64.54 | -30.59 | -11.97 | -2.92 | -6.97 | -4.57 | -9.44 | -13.7 | -16.2 | -44.09 | -60.57 | -118.02 | -88.51 |
P/OCF Ratio | -8.42 | -3.4 | -14.17 | -16.45 | -67.09 | -30.59 | -12.05 | -2.98 | -7.1 | -4.65 | -9.92 | -15.31 | -16.59 | -44.37 | -60.82 | -118.02 | -92.18 |
OCF/S Ratio | n/a | -4.6 | -3.46 | -1.57 | -0.41 | -5.96 | -7.36 | -2.77 | -7.13 | -8.81 | -10.21 | -4.15 | -1.6 | -3.47 | -1.28 | -2.16 | -1.84 |
Debt / Equity Ratio | 0.36 | 0.33 | 0.30 | 0.28 | 0.28 | 0.27 | 0.29 | 0.33 | 0.36 | 0.33 | 0.30 | 0.28 | 0.25 | 0.24 | 0.11 | 0.06 | 0.05 |
Quick Ratio | 5.06 | 5.70 | 5.71 | 6.31 | 5.09 | 5.08 | 6.34 | 7.39 | 6.09 | 7.95 | 6.46 | 7.19 | 6.90 | 6.45 | 6.36 | 8.47 | 10.81 |
Current Ratio | 5.06 | 5.70 | 5.71 | 6.31 | 5.09 | 5.08 | 6.34 | 7.39 | 5.69 | 7.07 | 6.46 | 7.19 | 6.90 | 6.45 | 6.36 | 8.47 | 10.81 |
Asset Turnover | n/a | 0.02 | 0.01 | 0.04 | 0.03 | 0.01 | 0.01 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 | 0.04 | 0.02 | 0.02 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -166.51 | -62.61 | -59.78 | -63.72 | -58.64 | -51.28 | -59.52 | -28.3 | -45 | -41.49 |
Return on Equity | -0.15 | -0.13 | -0.16 | -0.1 | -0.07 | -0.11 | -0.14 | -0.13 | -0.15 | -0.13 | -0.12 | -0.1 | -0.08 | -0.09 | -0.04 | -0.06 | -0.05 |
Return on Assets | -0.09 | -0.08 | -0.1 | -0.07 | -0.05 | -0.07 | -0.09 | -0.08 | -0.1 | -0.09 | -0.08 | -0.07 | -0.06 | -0.06 | -0.03 | -0.05 | -0.04 |
Return on Invested Capital | -0.11 | -0.1 | -0.12 | -0.08 | -0.06 | -0.09 | -0.11 | -0.09 | -0.11 | -0.1 | -0.09 | -0.07 | -0.06 | -0.07 | -0.03 | -0.05 | -0.05 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | 1.00 | 0.66 | 0.87 | 0.83 | 0.33 | 0.48 | 0.82 | 0.25 | 0.45 | 0.29 | 0.72 | 0.85 | 0.81 | 0.96 | -1.86 | -1.38 |
Net Profit Margin | n/a | -3.64 | -6.68 | -1.61 | -1.48 | -9.33 | -10.66 | -2.44 | -13.48 | -9.03 | -12.64 | -4.65 | -1.98 | -4.16 | -0.78 | -2.9 | -2.31 |
Pretax Profit Margin | n/a | -3.64 | -6.65 | -1.61 | -1.48 | -9.33 | -10.57 | -2.35 | -13.48 | -9.25 | -13.03 | -4.73 | -1.98 | -4.13 | -0.78 | -2.9 | -2.31 |
Operating Profit Margin | n/a | -4.03 | -7.28 | -1.84 | -1.79 | -10.6 | -11.48 | -2.51 | -14.1 | -9.64 | -13.42 | -4.81 | -1.98 | -4.1 | -0.76 | -2.85 | -2.26 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | -3.97 | -6.31 | -1.47 | -1.31 | -8.67 | -10.05 | -2.16 | -12.51 | -8.54 | -12.11 | -4.37 | -1.79 | -3.87 | -0.72 | -2.8 | -2.18 |